Management of recurrent viral Hepatitis B and C after liver transplantation

Marzia Montalbano, Guy W. Neff

Research output: Contribution to journalArticlepeer-review


Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contra-indication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment-outcomes for HCV and HBV in the period following liver transplant.

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalCurrent Gastroenterology Reports
Issue number1
Publication statusPublished - Feb 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of recurrent viral Hepatitis B and C after liver transplantation'. Together they form a unique fingerprint.

Cite this